| 产品描述: | M4K2234, a chemical probe, is an orally active, highly selective inhibitor of ALK1 and ALK2 with IC50 values of 7 nM and 14 nM, respectively. M4K2234 specifically blocks BMP signaling by inhibiting the phosphorylation of SMAD1/5/8. M4K2234 inhibits BMP7-stimulated reporter gene activity (IC50 = 16 nM). M4K2234 can be used for the investigation of ALK1/2-mediated biological processes and related diseases such as diffuse midline glioma (DMG) and fibrodysplasia ossificans progressiva (FOP). |
| 靶点: |
ALK1:7 nM (IC50); ALK2:14 nM (IC50); ALK3:168 nM (IC50); ALK4:1660 nM (IC50); ALK5:1950 nM (IC50); ALK6:88 nM (IC50) |
| 体内研究: |
M4K2234 (16 nM) 在 HEK293 细胞中强效抑制 BMP7 刺激的报告基因活性,对激活素 A 和 TGF-β1 诱导的 CAGA 反应性报告基因的抑制作用分别弱 50 倍和 150 倍。 M4K2234 (0.5-1 μM) 在 HEK293T 细胞中特异性抑制 BMP 家族配体诱导的 SMAD1/5/8 磷酸化,不影响激活素 A 或 TGF-β1 诱导的 SMAD2/3 磷酸化。 M4K2234 在酶动力学实验中对 ALK1 和 ALK2 的 IC50 分别为 7 nM 和 14 nM,对 ALK6 的抑制较弱 (88 nM),对 ALK4/5 的活性可忽略 (>10,000 nM)。 |
| 参考文献: |
1. Němec V, et al. Discovery of Two Highly Selective Structurally Orthogonal Chemical Probes for Activin Receptor-like Kinases 1 and 2. J Med Chem. 2024 Aug 8;67(15):12632-12659. |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.162 ml |
10.809 ml |
21.619 ml |
| 5 mM |
0.432 ml |
2.162 ml |
4.324 ml |
| 10 mM |
0.216 ml |
1.081 ml |
2.162 ml |
| 50 mM |
0.043 ml |
0.216 ml |
0.432 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |